rs727504747
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1PM2PM5PP3PP5_Moderate
The NM_005343.4(HRAS):c.175_176delinsCT(p.Ala59Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A59T) has been classified as Likely pathogenic.
Frequency
Genomes: not found (cov: 33)
Consequence
HRAS
NM_005343.4 missense
NM_005343.4 missense
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.82
Genes affected
HRAS (HGNC:5173): (HRas proto-oncogene, GTPase) This gene belongs to the Ras oncogene family, whose members are related to the transforming genes of mammalian sarcoma retroviruses. The products encoded by these genes function in signal transduction pathways. These proteins can bind GTP and GDP, and they have intrinsic GTPase activity. This protein undergoes a continuous cycle of de- and re-palmitoylation, which regulates its rapid exchange between the plasma membrane and the Golgi apparatus. Mutations in this gene cause Costello syndrome, a disease characterized by increased growth at the prenatal stage, growth deficiency at the postnatal stage, predisposition to tumor formation, cognitive disability, skin and musculoskeletal abnormalities, distinctive facial appearance and cardiovascular abnormalities. Defects in this gene are implicated in a variety of cancers, including bladder cancer, follicular thyroid cancer, and oral squamous cell carcinoma. Multiple transcript variants, which encode different isoforms, have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
PM1
?
In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 10 uncertain in NM_005343.4
PM2
?
Very rare variant in population databases, with high coverage;
PM5
?
Other missense variant is known to change same aminoacid residue: Variant chr11-533881-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 40435.Status of the report is reviewed_by_expert_panel, 3 stars.
PP3
?
No computational evidence supports a deleterious effect, but strongly conserved according to phyloP
PP5
?
Variant 11-533880-GC-AG is Pathogenic according to our data. Variant chr11-533880-GC-AG is described in ClinVar as [Likely_pathogenic]. Clinvar id is 179260.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HRAS | NM_005343.4 | c.175_176delinsCT | p.Ala59Leu | missense_variant | 3/6 | ENST00000311189.8 | |
HRAS | NM_176795.5 | c.175_176delinsCT | p.Ala59Leu | missense_variant | 3/6 | ENST00000417302.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HRAS | ENST00000311189.8 | c.175_176delinsCT | p.Ala59Leu | missense_variant | 3/6 | 1 | NM_005343.4 | P1 | |
HRAS | ENST00000417302.7 | c.175_176delinsCT | p.Ala59Leu | missense_variant | 3/6 | 5 | NM_176795.5 |
Frequencies
GnomAD3 genomes ? Cov.: 33
GnomAD3 genomes
?
Cov.:
33
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome ? Cov.: 33
GnomAD4 genome
?
Cov.:
33
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Costello syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 14, 2014 | The Ala59Leu variant in HRAS has now been identified in one individual with clin ical features of a Noonan spectrum disorder and was not identified in the parent s of this individual. This variant has not been previously reported in the liter ature or identified in large population studies. However, an alanine to threonin e change at the same codon in the HRAS gene has been found to segregate in three individuals within one family, all of whom reportedly have clinical features of the Noonan spectrum (LMM unpublished data). In addition, the alanine amino acid is highly conserved across evolutionarily-distinct species, and computational a nalyses (biochemical amino acid properties, AlignGVGD, PolyPhen2, and SIFT) sugg est that this variant may impact the normal function of the protein. In summary, this variant is likely pathogenic, though additional studies are required to fu lly establish its clinical significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at